ArticleJournal of cancer prevention2017

Non-homologous End Joining Inhibitor SCR-7 to Exacerbate Low-dose Doxorubicin Cytotoxicity in HeLa Cells.

Ajay Kumar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.